اخبار

منابع آزمون روانپزشکی1403(60 مقاله)

57.Clinical signs in functional cognitive disorders: A systematic review and diagnostic meta-analysis 57.Clinical signs in functional cognitive disorders: A systematic review and diagnostic meta-analysis
56.Cognitive Errors Associated With Medical DecisionMaking: A Systematic Review 56.Cognitive Errors Associated With Medical DecisionMaking: A Systematic Review
55.Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial 55.Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial
54.Nonsuicidal self‐ injury and rumination: A meta‐ analysis 54.Nonsuicidal self‐ injury and rumination: A meta‐ analysis
53.Personality disorders, depression and anxiety in mothers of children with ADHD and anxiety disorders in Iran 53.Personality disorders, depression and anxiety in mothers of children with ADHD and anxiety disorders in Iran
52.Citalopram-induced sleep bruxism in a breastfed infant: A case report 52.Citalopram-induced sleep bruxism in a breastfed infant: A case report
49.Pharmacological memory modulation to augment trauma-focused psychotherapy for PTSD: a systematic review of randomised controlled trials 49.Pharmacological memory modulation to augment trauma-focused psychotherapy for PTSD: a systematic review of randomised controlled trials
48.Diagnosis and treatment of borderline personality disorder in young people 48.Diagnosis and treatment of borderline personality disorder in young people
47.A comparison between auditory hallucinations, interpretation of voices, and formal thought disorder in dissociative identity disorder and schizophrenia spectrum disorders 47.A comparison between auditory hallucinations, interpretation of voices, and formal thought disorder in dissociative identity disorder and schizophrenia spectrum disorders
46.Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder 46.Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder
45.Association of impulsivity with quality of life and well‐ being after alcohol withdrawal treatment 45.Association of impulsivity with quality of life and well‐ being after alcohol withdrawal treatment
44.Adjunctive memantine for opioid use disorder treatment: a systematic review 44.Adjunctive memantine for opioid use disorder treatment: a systematic review
43.Somatization and Somatic Symptom Disorder and its overlap with dimensionally measured personality pathology: A systematic review 43.Somatization and Somatic Symptom Disorder and its overlap with dimensionally measured personality pathology: A systematic review
42.To Predict, Prevent, and Manage PostTraumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers 42.To Predict, Prevent, and Manage PostTraumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers
41.Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study 41.Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study
40.Lithium treatment in the prevention of repeat suicide-related outcomes in veterans with major depression or bipolar disorder: a randomized clinical trial 40.Lithium treatment in the prevention of repeat suicide-related outcomes in veterans with major depression or bipolar disorder: a randomized clinical trial
39.The effect of adding curcumin to sodium valproate in treatment of patients with bipolar disorder in the acute phase of mania: A randomized double-blind clinical tria 39.The effect of adding curcumin to sodium valproate in treatment of patients with bipolar disorder in the acute phase of mania: A randomized double-blind clinical tria
38.Association between physical activity and risk of depression: a systematic review and meta-analysis 38.Association between physical activity and risk of depression: a systematic review and meta-analysis
37.Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale 37.Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale

34.Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes 34.Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes
33.Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets 33.Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets
32.The diagnosis and treatment of catatonia 32.The diagnosis and treatment of catatonia
31.Long‐ term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta‐ analysis 31.Long‐ term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta‐ analysis
30.Mental health care for older adults: recent advances and new directions in clinical practice and research 30.Mental health care for older adults: recent advances and new directions in clinical practice and research
28.Distinguishing Behavioral Variant Frontotemporal Dementia from primary psychiatric disorders: A review of recently published consensus recommendations from the Neuropsychiatric International Consortium for Frontotemporal Dementia 28.Distinguishing Behavioral Variant Frontotemporal Dementia from primary psychiatric disorders: A review of recently published consensus recommendations from the Neuropsychiatric International Consortium for Frontotemporal Dementia
27.Placebo responses and placebo effects in functional gastrointestinal disorders 27.Placebo responses and placebo effects in functional gastrointestinal disorders
26.REM sleep loss–induced elevated noradrenaline could predispose an individual to psychosomatic disorders: a review focused on proposal for prediction, prevention, and personalized treatment 26.REM sleep loss–induced elevated noradrenaline could predispose an individual to psychosomatic disorders: a review focused on proposal for prediction, prevention, and personalized treatment
25.Optimizing first line treatments for adults with OCD 25.Optimizing first line treatments for adults with OCD
Optimizing first line treatments for adults with OCD
24.Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials 24.Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials
23.Time course of symptoms in posttraumatic stress disorder with delayed expression: A systematic review 23.Time course of symptoms in posttraumatic stress disorder with delayed expression: A systematic review
22.Psychological therapies for post-traumatic stress disorder in adults: Systematic review and meta-analysis 22.Psychological therapies for post-traumatic stress disorder in adults: Systematic review and meta-analysis
21.Treatment combinations for Alzheimer’s disease: current and future pharmacotherapy options 21.Treatment combinations for Alzheimer’s disease: current and future pharmacotherapy options
20.Dementia prevention, intervention, and care: 2020 report of the Lancet Commission 20.Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
19.Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress 19.Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress
17.Treatment of anorexia nervosa—new evidence-based guidelines." Journal of clinical medicine 8: 2 (2019): 153. https://doi.org/10.3390/jcm8020153 18. Elizabeth Joe, and John M. Ringman 17.Treatment of anorexia nervosa—new evidence-based guidelines
16.Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 16.Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
15.Management of functional neurological disorder 15.Management of functional neurological disorder
14.Diagnosis and management of functional neurological disorder 14.Diagnosis and management of functional neurological disorder
13.Comparative efficacy and acceptability of pharmaceutical management for adults with post-traumatic stress disorder: a systematic review and meta-analysis 13.Comparative efficacy and acceptability of pharmaceutical management for adults with post-traumatic stress disorder: a systematic review and meta-analysis
12.Pharmacotherapy for treatment-resistant obsessive-compulsive disorder 12.Pharmacotherapy for treatment-resistant obsessive-compulsive disorder
11.Pharmacotherapy of anxiety disorders: current and emerging treatment options 11.Pharmacotherapy of anxiety disorders: current and emerging treatment options
10.Treatment of mixed features in bipolar disorder: an updated view 10.Treatment of mixed features in bipolar disorder: an updated view
9.Bipolar disorder and suicide: a review 9.Bipolar disorder and suicide: a review
8.Association between physical activity and risk of depression: a systematic review and meta-analysis 8.Association between physical activity and risk of depression: a systematic review and meta-analysis
6.Assessment of personality functioning in psychosomatic medicine. 6.Assessment of personality functioning in psychosomatic medicine.
5.Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis. 5.Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis.
4.Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. 4.Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.
3.Mortality in people with schizophrenia: a systematic review and meta‐ analysis of relative risk and aggravating or attenuating factors. 3.Mortality in people with schizophrenia: a systematic review and meta‐ analysis of relative risk and aggravating or attenuating factors.
2.Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis 2.Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis
1.Oral and long‐ acting antipsychotics for relapse prevention in schizophrenia‐ spectrum disorders: a network meta‐ analysis of 92 randomized trials including 22,645 participants 1.Oral and long‐ acting antipsychotics for relapse prevention in schizophrenia‐ spectrum disorders: a network meta‐ analysis of 92 randomized trials including 22,645 participants
۹ آبان ۱۴۰۲ ۰۹:۱۰

نظرات بینندگان

نام را وارد کنید
تعداد کاراکتر باقیمانده: 500
نظر خود را وارد کنید

ارسال